HTX-011 is a long-acting formulation of the local anesthetic bupivacaine in a fixed-dose combination with the anti-inflammatory meloxicam. Around 60 patients undergoing inguinal hernia repair will be included
As part of the deal, PharmaMar will receive an upfront payment, royalties and additional remunerations for regulatory milestones achieved by Aplidin. The deal will see PharmaMar retain exclusive
Currently, Olysio is approved for use with sofosbuvir for adults with genotype 1 chronic hepatitis C (CHC) infection as a 12-week treatment for patients without cirrhosis or a
The company intends to start the trial upon investigational review board approvals and expects the first subject to be dosed within two months. LPA is a bioactive lipid
The company noted that validation of the applications confirms that the submissions are complete and starts the EMA’s centralized review process. In lung cancer, the proposed new indication
The expanded indication of Kyprolis is for these patients who have received at least one prior therapy. Currently, Kyprolis has accelerated approval in the US to treat patients
The drug is approved for patients with HAP and VAP known or suspected to be caused by susceptible isolates of Staphylococcus aureus including methicillin-susceptible and methicillin-resistant S. aureus
The results were presented at the World Health Organization’s (WHO) fifth teleconference on Ebola vaccine clinical trials. The results showed that the Ebola GP Vaccine was highly immunogenic,
The initial agreement announced in February 2014 focused on the discovery and development of five pre-defined Nanobody candidates directed towards immune checkpoint modulator targets for evaluation as immunotherapies
The approval is based on data from three clinical studies including Phase Ib KEYNOTE-001 trial, Phase II KEYNOTE-002 trial and Phase III KEYNOTE-006 trial conducted in more than
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.